ROCHE HOLDING LTD. |
End-of-day quote
Other stock markets
|
||
| - CHF | - |
|
| 07:28am | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
| 07:00am | Europe stock pickers go old-school to ride the next wave in AI | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 60.06B 65.88B | Sales 2025 * | 63.61B 69.78B | Capitalization | 189B 208B |
|---|---|---|---|---|---|
| Net income 2024 * | 13.41B 14.71B | Net income 2025 * | 14.87B 16.31B | EV / Sales 2024 * | 3.38 x |
| Net Debt 2024 * | 13.75B 15.08B | Net Debt 2025 * | 7.73B 8.48B | EV / Sales 2025 * | 3.1 x |
| P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
12.4
x | Employees | - |
| Yield 2024 * |
4.15% | Yield 2025 * |
4.29% | Free-Float | 88.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Roche Holding Ltd.
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
| Director/Board Member | 59 | - | |
| Director/Board Member | 66 | 95-12-31 |
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
Pharmaceuticals
Calendar
07:30am
- Investor Day
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +37.78% | 723B | |
| +32.82% | 598B | |
| -3.51% | 364B | |
| +19.94% | 331B | |
| +5.14% | 288B | |
| +16.64% | 244B | |
| +10.63% | 210B | |
| +9.32% | 169B | |
| -0.80% | 162B |
